Evolent Health Inc $ 7.25 0.28 (4.02%)
Volume:
509,604
Avg Vol (1m):
1,314,868
Market Cap $:
613.62 Mil
Enterprise Value $:
833.92 Mil
P/E (TTM):
0.00
P/B:
0.51
Manual of Stocks™ Web
Financial Strength | 4.8/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.32 | ||
| Equity-to-Asset | 0.68 | ||
| Debt-to-Equity | 0.27 | ||
| Debt-to-EBITDA | -6.83 | ||
| Piotroski F-Score | 2 | ||
| Altman Z-Score | 0.96 | ||
| Beneish M-Score | -2.57 | ||
| WACC vs ROIC | |||
Profitability | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -14.77 | ||
| Net Margin % | -14.67 | ||
| ROE % | -9.85 | ||
| ROA % | -7.03 | ||
| ROC (Joel Greenblatt) % | -96.86 | ||
| 3-Year Revenue Growth Rate | 56.9 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 0.51 | ||
| PS Ratio | 0.8 | ||
| EV-to-EBIT | -8.48 | ||
| EV-to-EBITDA | -18.92 | ||
| EV-to-Revenue | 1.15 | ||
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.39 | ||
| Days Sales Outstanding | 35.55 | ||
| Days Payable | 25.44 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.4 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 18.61 | ||
| Price-to-Median-PS-Value | 0.23 | ||
| Earnings Yield (Greenblatt) % | -11.8 |